Canada - TSX-V:MPH - CA58469E4085 - Common Stock
The current stock price of MPH.CA is 1 CAD. In the past month the price decreased by -16.67%. In the past year, price decreased by -13.04%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EDT.CA | SPECTRAL MEDICAL INC | N/A | 485.89M | ||
FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 355.67M | ||
EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 264.31M | ||
TH.CA | THERATECHNOLOGIES INC | N/A | 210.13M | ||
HBP.CA | HELIX BIOPHARMA CORP | N/A | 116.10M | ||
WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 100.71M | ||
MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 88.41M | ||
BLU.CA | BLUENERGIES LTD | N/A | 82.42M | ||
NRX.CA | NUREXONE BIOLOGIC INC | N/A | 72.01M | ||
MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 67.23M | ||
COV.CA | COVALON TECHNOLOGIES LTD | 16.92 | 60.32M | ||
SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 47.21M |
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. The company is headquartered in Winnipeg, Manitoba and currently employs 23 full-time employees. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. The company operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. The company operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. The company develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
MEDICURE INC
1250 Waverley Street
Winnipeg MANITOBA R3T 6C6 CA
CEO: Albert D. Friesen
Employees: 38
Phone: 12044877412
The current stock price of MPH.CA is 1 CAD. The price decreased by -10.71% in the last trading session.
The exchange symbol of MEDICURE INC is MPH and it is listed on the TSX Venture Exchange exchange.
MPH.CA stock is listed on the TSX Venture Exchange exchange.
MEDICURE INC (MPH.CA) has a market capitalization of 10.44M CAD. This makes MPH.CA a Nano Cap stock.
MEDICURE INC (MPH.CA) currently has 38 employees.
MEDICURE INC (MPH.CA) has a resistance level at 1.13. Check the full technical report for a detailed analysis of MPH.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MPH.CA does not pay a dividend.
MEDICURE INC (MPH.CA) will report earnings on 2025-11-24.
MEDICURE INC (MPH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.32).
ChartMill assigns a technical rating of 2 / 10 to MPH.CA. When comparing the yearly performance of all stocks, MPH.CA is a bad performer in the overall market: 64.19% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to MPH.CA. While MPH.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months MPH.CA reported a non-GAAP Earnings per Share(EPS) of -1.32. The EPS decreased by -700% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -5.99% | ||
ROE | -8.88% | ||
Debt/Equity | 0.02 |